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Summary  Since  its  discovery  in  1947  in  Uganda  and  control  and  eradication  efforts
have  aimed  at  its  vectors  (Aedes  mosquitoes)  in  Latin  America  in  the  1950s,  an
absolute  neglect  of  Zika  programs  and  interventions  has  been  documented  in  Aedes
endemic  and  epidemic-prone  countries.  The  current  unprecedented  Zika  viral  epi-
demics  and  rapid  spread  in  the  Western  hemisphere  pose  a  substantial  global  threat,
with  associated  anxiety  and  consequences.  The  lack  of  safe  and  effective  drugs  and
vaccines  against  Zika  or  dengue  epidemics  further  buttresses  the  realization  from
the  West  Africa  Ebola  outbreak  that  most  emerging  disease-prone  countries  are
still  poorly  prepared  for  an  emergency  response.  This  paper  examines  knowledge
gaps  in  both  emerging  and  neglected  arthropod-borne  ﬂavivirus  infectious  diseases
associated  with  poverty  and  their  implications  for  fostering  local,  national  and
regional  emerging  disease  preparedness,  effective  and  robust  surveillance—response
systems,  sustained  control  and  eventual  elimination.  Strengthening  the  regional
and  Global  Health  Flavivirus  Surveillance-Response  Network  (GHFV-SRN)  with  other
models  of  socio-economic,  climatic,  environmental  and  ecological  mitigation  and
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adaptation  strategies  will  be  necessary  to  improve  evidence-based  national  and  global
maternal—child  health  agenda  and  action  plans.
©  2016  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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ntroduction
he  unprecedented  and  emerging  Zika  epidemic  is
 public  health  threat  of  international  concern  in
he Western  hemisphere  that  is  spreading  quickly
nd causing  havoc.  More  than  two  million  people
ave been  affected  to  date,  with  multiple  health
nd socio-economic  consequences.  This  infectious
isease  of  poverty  was  ﬁrst  discovered  in  Uganda
n 1947;  only  15  cases  were  documented  prior
o 2007,  and  the  disease  remained  in  a  state  of
ormancy  until  now  [1].  It  has  been  identiﬁed
n more  than  20  countries  in  South  and  Central
merica, the  Caribbean,  Asia-Paciﬁc  and  Africa  and
ome Paciﬁc  islands  (Fiji,  Vanuatu,  Micronesia)  have
lso reported  sporadic  outbreaks  [2—4].  Arbovirus
isease epidemics  have  the  potential  to  worsen
he global  maternal—child  health  burden  in  most
ector-borne disease-prone  countries  [5]  (Fig.  1).
Zika  is  caused  by  an  arthropod-borne  virus
‘arbovirus’’ transmitted  primarily  by  Aedes
osquito (Aedes  aegypti  and  Aedes  albopictus)
blood  and  other  bodily  ﬂuids  such  as  semen  during
sexual intercourse  or mother-to-fetus  transmission
throughout pregnancy  [2]. ZIKV  disease  outbreaks
have been  linked  with  pregnancy  syndrome,  new-
born and  child  defects  and  premature  deaths  [1,2].
Colombia has  recoded  13,500  suspected  cases  and
predicts 600,000  cases  by  the  end  of  2016  with
signiﬁcant social,  health  and  economic  impacts.
In comparison,  Brazil  reported  4000  cases  of  fetal
microcephaly  during  pregnancy  yet  had  only  150
cases total  in  2015  and  2014,  respectively.  In
addition,  of  the  25,165  infected  cases,  more  than
3177 pregnant  women  have  been  documented  with
the ZIKV  in  Colombia  [6,7]. There  is  an  urgent
need for  innovative  approaches  and  tools  for  early
detection  and  rapid  conﬁrmation  of  ZIKV-linked
microcephaly  and  early  warning  systems  to  provide
timely  evidence-based  information  to  guide  deci-
sion making  policies  and  strategies  including  pre-
and ante-natal  counseling  and  strict  abortion
measures. We  also  need  new  methods  for  managing
climate change,  environmental  and  ecologicalite. Zika  is also  part  of  the  ﬂavivirus  family
hat also  includes  dengue,  West  Nile  and  yellow
ever. Zika  virus  (ZIKV)  can  be  transmitted  through
s
h
pystems in  hospital  and  maternity  settings  and
ygiene and  sanitation  efforts  to  interrupt  any
otential  sources  of  transmission.
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cFigure  1  Reported  and  active  tran
This  paper  examines  the  knowledge  gaps  of
these emerging  and  neglected  infectious  diseases
of poverty  epidemics  (Zika  and  dengue)  impli-
cations in  fostering  local,  national  and  regional
emerging threats  and  epidemics  preparedness,
surveillance  and  smart  response  systems  for  sus-
tained maternal—child  health.
Methodology
Search strategy
Systematic  review  results  from  searches  for  Zika
and dengue  outbreak-affected  countries  using  key
MeSH terms  including  ‘‘Zika  or  dengue  outbreak,
ZIKV/DENV, Zika  or  dengue  arthropod-borne  ﬂa-
viviruses vector  threat  and  epidemics  surveillance,
Zika viral  outbreak  response,  Aedes  mosquito  con-
trol, dengue  control  programs  and  maternal—child
health interventions’’  along  with  terms  refer-
ring to different  types  of  outbreak  responses  and
interventions,  those  indexed  in  PubMed,  data  pub-
lished in  acknowledged  websites  and  national  and
regional reports  were  reviewed.  This  was  done
to assess  the  emerging  Zika  and  dengue  public
health threat  and  burden,  surveillance  and  con-
trol programs  and  effectiveness  of  interventions  in
affected countries.
Inclusion and selection criteria
Systematic  review  information  and  data  from  the
affected  countries  and  maternal—child  populations
were scrutinized  and  documented.  Data  sources
included the  results  from  all  acknowledged  web-
based  searches  useful  in  providing  detailed  analyses
of national  and  regional  trends,  health  strategies
and  measures  and  WHO  guidelines  for  outbreak
d
F
lion  of  Zika  viral  disease  countries.
urveillance  and  response  in  humanitarian  emer-
encies,  global  infectious  disease  surveillance,
pidemic preparedness  and  response,  Global  Alert
nd Response  and  the  Global  Outbreak  Alert  and
esponse  Network  documents  speciﬁcally  focused
n arbovirus/ﬂavivirus  (ZIKV  and  DENV).  Inclusion
riteria  for  studies  were  those  conducted  in  the
estern  hemisphere,  Africa  and  Paciﬁc  islands;
pidemics analyzed  over  time  and  space;  studies
n the  incidence,  prevalence  and  fatality  rates  in
ffected countries;  and  studies  focusing  on  pro-
rams and  emergency  response.  The  Centers  for
isease Control  and  Prevention’s  National  Noti-
able Dengue  Surveillance  databases  and  World
ealth Global  Outbreak  Emergency  Response  data
ere also  used.  The  data  obtained  were  summa-
ized and  used  to  describe  the  public  health  burdens
f ZIKV  and  DENV  diseases.
esults
 total  of  174  papers  were  analyzed;  31  were
elected based  on  ZIKV  and  DENV  surveillance
rograms and  maternal—child  health  interven-
ions in  Aedes  arthropod-borne  ﬂavivirus-affected
ountries.  Only  31  publications  that  met  the  inclu-
ion criteria  were  fully  assessed  and  analyzed,  with
espect to  the  prevention  of  disease  co-infection
urden and  maternity  and  pediatric  care  delivery
ervices.
hronological trend and general
haracteristics  of Zika and dengue viral
iseases epidemics
rom  its  discovery  in  Uganda  in  1947  and  its  iso-
ation in  Nigeria  in  2005  and  2007  and  Senegal  in
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tika  and  dengue  epidemics  implications  for  global  m
007,  the  Zika  virus  migrated  to  the  Middle  East
nd Southeast  Asia,  to  the  Paciﬁc  islands  and  to  the
estern hemisphere  and  the  Americas.  In  2015  and
016, Brazil  recorded  the  highest  number  of  cases
f microcephaly  (more  than  3800),  which  was  over
0 times  more  than  in  any  year  since  2010  (Fig.  1).
ika and dengue viral disease impact
mplications on global maternal—child
ealth  burden
oth  Zika  and  dengue  are  emerging  or  re-emerging
iral diseases  that  are  both  caused  by  the  arbovirus
‘Aedes species’’.  Both  Zika  and  dengue  infections
ppear to  have  similar  early  signs  and  symptoms
ncluding maculo-papular  rash,  fever,  back/body
ain; they  differ  in  their  late  stage  or  complica-
ion symptoms,  such  as  hemorrhagic  bleeding  in
engue.  Previous  dengue  epidemics  have  been  doc-
mented but  less  virulent  and  localized  than  the
ngoing  widespread  ZIKV  epidemics.  Nevertheless,
here is  still  much  to  be  learned  regarding  the
ull human  impact  of  ZIKV  compared  to  the  patho-
hysiological and  immunological  consequences  of
engue virus.  ZIKV  can  be  transmitted  to  humans
y infected  Aedes  mosquito  bites,  infected  mother-
o-child  trans-placenta  bodily  ﬂuid  diffusion,  blood
ransfusion,  unprotected  sexual  intercourse  with
n infected  individual  and  perhaps  breastfeed-
ng. More  short  and  long-term  operational  research
s needed  to  further  establish  the  risk  factors
nd determinants  and  to  conﬁrm  the  association
etween Zika  virus  infections,  microcephaly  and
elated  neurological  aberrations  suspected  in  fetal
nd childhood  development  (Table  1).
reatment or vaccination against ZIKV and
ENV disease prevention and control
n  the  absence  of  safe  and  effective  Zika  or
engue drugs  and  vaccines,  addressing  the  local
nd national  Zika  public  health  emergency  and
lobal concern  requires  a  full  understanding  of
he social,  ecological  and  contextual  risk  factors
nd determinants  of  emerging  disease  outbreaks.
urrently, only  palliative  treatments  including  anti-
nﬂammatory  and  antiviral  treatment  options  are
eadily available  for  patient  management.
Enhancing community-based  social  mobilization
nd engagement,  awareness  campaigns  and  out-
each, vigilance  and  monitoring  of  early  warning
ignals fosters  health  system  capacity  develop-
ent (e.g.,  infrastructure  and  human  resources)
nd community  partnerships  and  leadership.  In
ddition,  effective  community  resilience  and
a
c
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mpowerment,  prevention  and  care  management
nd containment  emergency  responses  across
ndemic or  epidemic  prone  countries  are  vital.  Ade-
uate training  of  healthcare  workers  is  needed  to
ffectively carry  out  effective  and  efﬁcient  commu-
ication  operations  as  well  as  community  literacy,
revention,  care  and  containment  (e.g.,  patient
solation)  and  management  approaches.
The  differential  diagnosis  of  ZIKV  and  DENV
osquito-borne  illnesses  by  health  workers  or  local
hysicians  can  be  very  challenging  because  of
he similarities  in  signs  and  symptoms.  Molecu-
ar diagnostic  assay  results  from  sophisticated  and
ifferential  medical  interpretations  (e.g.,  ultra-
onography,  MRI,  RT  PCR  assay)  are  not  often
vailable and  accessible  and  are  also  expensive
or vulnerable  populations  in  remote  rural  and
emi-urban  settings.  Other  alternative  solutions
nclude  providing  advocacy  and  mitigation  plat-
orms against  climate  changes,  urbanization  and
lobalization  approaches  to  reducing  mother-to-
hild transmission,  comprehensive  antenatal  and
ostnatal  programs  for  women,  sexual  education
nd use  of  protective  tools  and  measures,  adher-
nce  and  quality  outcomes.  Containing  the  current
ublic health  scourge  of  ZIKV  and  DENV  diseases
ill require  the  integration  of  population-based
ass drug  administration  and  immunization  inter-
entions supported  by  robust  evidence-based  and
ntegrated  epidemiological,  socio-cultural,  climatic
nd environmental  surveillance  and  information
anagement  to  guide  decision-making  policy  and
apid responses.  Nevertheless,  implementation  of
eal time,  contextual  and  practical  laws  and  reg-
lations  focusing  on  positive  social  behavioral
ttitudes and  perceptions  is needed  to  strengthen
ealth systems,  nurture  safe  motherhood  and  child-
ood practices  and  foster  evidence-driven  com-
unity  project  ownership  to  accelerate  recovery
rograms and  activities  in  affected  communities.
trengthening vector-borne disease
reparedness and surveillance—response in
aternal and neonatal child health
eak  or  lack  of  health  system  preparedness  and
mergency  response,  lack  or  inadequacies  in  early
etection  and  diagnostics,  lack  of  surveillance
ndicators and  benchmarks,  lack  of  tracing  and
racking  and  lack  of  effective  risk  communica-
ion and  reporting  tools  and  resources  in  Zika
nd other  emerging  infectious  diseases  are  major
hallenges  in  most  affected  countries.  The  poor
ccessibility  and  availability  of  care  services  to
ost vulnerable  populations  during  Zika  epidemics
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Table  1  Key  comparative  characteristics  between  Zika  and  dengue  viral  disease  threats  and  epidemics.
Characteristics  Zika  Dengue  References
Discovery  year  1947  Uganda
Zika  virus  isolation  in  monkey  and
human  in  1952  and  1954  in  Nigeria,
respectively
265—420  AD
Aedes  conﬁrmation  in  1906
[1,4]
Disease  type  Viral  arthropod-borne  ﬂavivirus  Viral  arthropod-borne  ﬂavivirus
Vector  mosquito  Aedes  aegypti,  Aedes  albopictus  Aedes  aegypti,  Aedes  albopictus
Genius,  family  and
member
Genus  Aedes, Arbovirus/ﬂavivirus,
Flaviviridae
Genus  Aedes, Arbovirus/ﬂavivirus,
Flaviviridae
[3,10]
Virus  types Zika  virus  (ZIKV1,  2,  3) DENV1,  2,  3,  4  virus
Transmission Infected  vector/Aedes  bite
Infected  ﬂuids:  blood,  semen,  rectal
ﬂuids,  vaginal  ﬂuids,  mother-to-child
transmission  via  breast  milk.  Blood
transfusion  or  needle  exchange
Mosquito  Aedes  bite
Unprotected  sexual  intercourse
Infected  ﬂuids:  blood,  semen,  rectal
ﬂuids,  vaginal  ﬂuids,  mother-to-child
transmission  via  breast  milk  or  blood
transfusion  suspected
[11,13,23]
Route  of  transmission  Human-to-human  transmission
Wildlife-to-human  by  infected  Aedes
bite
Direct  contact  with  infected  body
ﬂuids,  blood  of  infected  human  and
animal  including  blood,  urine,  sweat,
semen  and  breast  milk  (sweat,  semen,
saliva)
Human-to-human  transmission
Wildlife-to-human  by  infected  Aedes
bite
Direct  contact  with  infected  body
ﬂuids,  blood  of  infected  human  and
animal  including  blood,  urine,  sweat,
semen  and  breast  milk  (sweat,  semen,
saliva)
[1,12,13,15,16,22]
Incubation  2—23  days  Usually  2—21  days
Host  reservoir  Human,  gorillas,  monkeys,  apes  and
chimpanzees
Human  and  animals
Susceptible  countries  >50  Africa  (Cape  Verde,  Central
African  Republic,  Egypt,  Gabon,  Sierra
Leone,  Tanzania,  Nigeria  and  Uganda),
Southeast  Asia  and  the  Paciﬁc  Islands
(including  India,  Indonesia,  Malaysia,
the  Philippines,  Thailand  and  Vietnam,
Samoa),  South  and  Central  America
(Brazil,  Colombia,  Mexico,  Venezuela,
Ecuador,  Jamaica,  El  Salvador,  Haiti,
Honduras,  Puerto  Rico),  Asia-Paciﬁc
Islands  (Fiji,  Vanuatu,  Micronesia)
>100  Countries  in  Africa,  Southeast
Asia,  the  Paciﬁc  Islands  and  middle
East  including  (Uganda,  South  and
Central  America,  Brazil,  Colombia,
Mexico,  Venezuela,  El  Salvador,  Haiti,
Honduras,  Puerto  Rico),  Asia-Paciﬁc
(China,  Malaysia,  India,  Pakistan,  Fiji,
Vanuatu,  Micronesia)  and  Saudi  Arabia
[1—3,14]
Zika
 and
 dengue
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Risk  factors/determinants  Global  trade  and  travel,  Tourism  in
Enzootic  or  Aedes-prone  settings,
Unsafe  sexual  behavior,  probably  from
patients’  body  ﬂuids,  breastfeeding  or
transplacental  or  virus  infected
materials
Poverty  and  insecurity
Unsafe  sexual  behavior,  probably  from
patients’  body  ﬂuids,  breast  milk,
unsterilized  virus  infected  needles  and
materials
[3,6,22,23]
Signs  and  symptoms Fever  and  arthralgia
Joints  pain  and  conjunctivitis,  Rash,
headaches,  Guillain—Barre  syndrome,
increasing  congenital  microcephaly  or
birth  defects  or  neurological  disorders
in  babies/newborns,  stillbirths  and
miscarriage,  and  poor  pregnancy
outcomes
High  fever  (40 ◦C/104 ◦F)
Severe  headache,  Pain  behind  the  eyes
Muscle  and  severe  abdominal  joint
pain
Swollen  glands  or  rash  nausea,
vomiting
Complications  include  ﬂuid
accumulation,  respiratory  distress,
severe  bleeding,
Restlessness  and  blood  in  vomit  or
organ  impairment
[4,7,14,25]
Global  incidence  —  NA  <284—528  million  infections  annually  [1,2]
Global  cumulative  cases >2  million >652,212  cases  of  dengue  hemorrhagic
fever
67—136  million  cases  dengue  fever
Global  cumulative  deaths  —  NA  22,000  deaths  mainly  among  children
Diagnostic  methods Syndromic  screening  in  most  cases.
Travel  and  work  history  exposure  to
wildlife  Prognosis
Differential  diagnosis  by  detecting  of
viral  RNA  by  PCR/RT-PCR  and  proteins
antibodies  against  the  virus  in
infected  patient’s  blood  by  ELISA  or
Serum  neutralization  test.
Syndromic  screening  in  most  cases.
Travel  and  work  history  exposure  to
wildlife  prognosis
Differential  diagnosis  by  detecting  of
viral  RNA  by  PCR/RT-PCR  and  proteins
antibodies  against  the  virus  in
infected  patient’s  blood  by  ELISA  or
Serum  neutralization  test
[14,24]
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Table  1  (Continued)
Characteristics  Zika  Dengue  References
Preventive  and  control
options
— No  vaccine  or  drug  available
—  Health  education  and  community  social  mobilization,  awareness,  empowerment  and
resilience  culture
— Scaling  up  the  usage  of  repellents  containing  DEET,  picaridin  and  IR3535,  condom
promotion  and  ABC  HIV/STIs  approach
—  Family  planning  and  abortion  reforms  as  well  as  personal  protection,  improved  hygiene
and  sanitation
—  Intensive  care  with  the  very  few  antiviral  treatment  options  including
anti-inﬂammatory  drugs  and  oral  rehydration  therapy
—  Integration  of  active  and  comprehensive  threat  and  disease  surveillance  and  actions
systems
(1)  Integration  of  a  comprehensive  threat  and  disease  surveillance  and  actions  systems
(2)  Increasing  community  awareness  education  and  risk  communication
(3)  Scaling  up  Zika  and  dengue  screening  for  effective  treatment  and  care
(4)  Partnership  and  cooperation  among  stakeholders  in  emerging  infectious  prevention
and  control  programs  and  measures
[15,23,26,33]
Research  and
development  needs
— Effective  contextual  vector  control  programs  and  measures
—  Strengthening  integrated  and  effective  ZIKV  cross-border  preparedness  and  emergency
response
—  Establishment  of  contextual  local  surveillance—response  systems
and  capacity  development  (laboratories,  clinical  and  ﬁeld)
—  Community/environmental  health  workers,  case  management
Safe  and  effective  drugs  and  vaccines  development  with  sustained  political  commitment
and  ﬁnancial  investment  in  ZIKV  research
—  Sexual,  reproductive  and  mental  health  education  as  well  as  strict  legal  measures  on
abortion
—  Climate  change  mitigation,  environmental  management  and  adaptation
evidence-based  strategies  and  policies
—  Understanding  maternal  vulnerability  and  impact  on  reproductive  health  and  family
planning  policy
—  Addressing  co-infection  with  ZIKV  and  HIV  in  vulnerable  populations  on  maternal—child
health  stigmatization  and  fear
—  New  global  alliance  for  arbovirus/ﬂavivirus  or  vector-borne  diseases  agenda
[1,6,15,26,33]
NA, not available data.
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ncrease  maternal—child  vulnerability  in  remote
ural settings.  Improving  the  health  system  capacity
o respond  to  maternal  and  neonatal  health  chal-
enges  can  be  accomplished  by  timely,  credible  and
ctionable  data  inputs,  coverage  and  the  quality
f services  provided.  Implementers  require  ‘‘early-
arning  systems’’  to  provide  reliable,  user-friendly
nd cost-effective  programs  to  monitor  progress,  to
oster evidence-based  decision  making  and  optimal
esilient  culture  and  integrated  quality  packages,
ncluding mosquito-borne  disease  awareness  and
ealth education  campaigns,  mitigation  and  recov-
ry measures.  ZIKV  rates  might  be  underestimated
nd could  even  be  higher  because  confusion  with
ther diseases  with  similar  symptoms  could  be  mis-
eading due  to  acquired  immunity  to  other  tropical
nfections  in  ZIKV  human  reservoirs,  which  might
lso complicate  the  actual  Zika  cases.  ZIKV  trans-
ission  in  human  reservoirs  can  be  interrupted  with
EET/permethrin  clothing  repellents  as  Zika  pre-
ention  and  control  methods.
Evidence-based  interventions  and  support  pro-
ramming  can  be  provided  by  strengthening
ocal and  national  preparedness  as  well  as
urveillance—response  system  implementation  in
aternal, neonatal  and  child  health.  Accelerat-
ng the  process  of  local/national  ZIKV  and  DENV
mmunization is  critical  and  should  be  included  in
amily and  reproductive  health  planning,  nutrition
nd poverty  alleviation  programs,  programs  and
ervices  linking  communities  and  primary  health
acilities  and  referral  hospitals.  Moreover,  effective
nd sustainable  programs  and  measures  are  crucial
o increase  access  and  coverage  rates  to  reduce
ealth inequities,  poverty  and  the  maternal—child
ealth burden  in  most  emerging  infectious  disease
pidemic-prone  countries.
iscussion
ika  and  dengue  viral  diseases  have  posed  great
hallenges to  the  most  affected  countries,  mainly
n terms  of  maternal—child  health  impact.  Increas-
ng our  knowledge  regarding  co-infections  and
ealth  complications  requires  rapid  global  response
or effective  treatment  or  vaccines;  revamping
nnovative socio-cultural,  health  education  and
ommunication  approaches  require  more  research
n the  future.  Tackling  persistent  disease  resur-
ence by  intensifying  information  dissemination
nd innovative  actions  requires  educational  reforms
t all  levels,  faith-based  and  community-based
nterventions  for  emerging  disease  outbreak  pre-
aredness,  prevention  and  emergency  response  are
ll vital.
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ZIKV  and  DENV  infections  have  important
ealth consequences;  geographical,  structural
nd biological  risk  factors,  including  poor  com-
unity  engagement  and  lack  of  viral  disease
urveillance—response  systems,  have  several
elated implications  [6,8].  Table  1  shows  that  Zika
nd dengue  have  similar  structural  characteristics
ncluding fear,  discrimination  and  even  stigmati-
ation  [2,4,10,21].  Biologically,  the  viruses  have
imilar host  reservoirs,  likely  modes  of  transmission
nd spread  in  human  populations,  mainly  through
uman-to-human  behavioral  spread  [22,25].  This
ncludes exposure  to  bodily  ﬂuids  such  as  blood  and
emen. Zika  is  mainly  transmitted  via  unprotected
ex and  via  semen  during  poor  sanitary  practices
15]; however,  contact  with  infected  bodily  ﬂuids
s one  route  of  person-to-person  transmission
12,21]. The  incubation  period  of  both  viral  dis-
ases is  short  and  varies  between  2  and  23  days;
rogression  to  infectiousness  is  between  4  and  7
ays [21]. Blood-fed  Zika  mosquito  screening  and
onitoring  of  emerging  viral  diseases,  especially
n maternal  and  child  populations,  are  needed.
nraveling Aedes  vector  competence  and  genetic
volution determinants  could  not  only  provide
igniﬁcant insights  into  sudden  ZIKV  outbreaks,
ut can  also  provide  a better  understanding  of
irus epidemiology  and  ecology,  including  water
reeding  containers,  buckets,  ﬂower  pots,  tires  or
onstruction  sites  [14,15,22].
It  is  important  to  understand  the  risk  factors  and
ransmission  dynamics  of  ZIKV  and  DENV  to  plan
or future  infection  resurgence,  especially  in  vul-
erable regions.  Because  most  African  countries
ave limited  surveillance  indicators  to  assess  the
hreat of  re-emergence,  early  warning  disease
lerts, community  awareness  outreach  and  educa-
ion are  essential.  Both  Zika  and  dengue  are  spread
n a  similar  way,  via  body  ﬂuids,  and  they  cur-
ently do  not  have  an  effective  antiretroviral  cure
8,15,21].  Infections  caused  by  Ebola  hemorrhagic
ever have  killed  50—70%  of  their  victims;  70%  of
eople living  with  Zika  or  dengue  are  in  sub-Saharan
frica [3].  Although  Zika  can  be  highly  lethal  in
he fetus  during  pregnancy,  more  so  than  dengue
23,24]. The  number  of  dengue-infected  individ-
als globally  is  far  greater  than  the  number  of
ika-infected  individuals  [3,15]. Additionally,  Zika
nd dengue  are  largely  restricted  to  low-income
ountries affected  by  poverty,  civil  war,  high  mater-
al and  infant  mortality  rates,  low  education  levels
nd internal  strife  [16,18].  The  areas  currently  most
ffected by  Zika  include  forest  fringes  and  unsta-
le African  countries  [20,28,29]. These  areas  have
ery weak  health  systems,  which  accounts  for  the
e-emergence  of  these  infectious  diseases  [15,20].
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Therefore,  strengthening  community  health  sys-
tems and  fostering  effective  prevention  and  care
delivery  capacity  are  paramount.  Tourists  or  mobile
cross-border  migrants  in  affected  areas  are  at
higher risk  of  a  disproportionate  burden,  especially
vulnerable newborns,  children  and  mothers,  who
easily travel  from  one  area  to  another  [30,31].
This can  stretch  the  already  fragile  health  systems
of these  affected  settings  and  increase  the  vector
or arbovirus  transmission  rates,  which  can  spread
unrecognized  and  from  underdiagnosed  reservoirs
[16,32].
Preventing  a  Zika-style  epidemic  crisis  requires
more evidence-based  innovative  prevention  and
control approaches  and  interventions.  Implementa-
tion of  effective  and  sustainable  interventions  such
as community  social  engagement  and  participation
outreach, prompt  identiﬁcation  and  case  man-
agement,  surveillance  and  preparedness  systems,
contact  tracing,  laboratory  diagnosis,  community
mobilization, recovery  systems  for  survivors,  safe
burial practices  and  behavioral  changes  (e.g.,
promotion of  condom  usage.  abstinence,  ante-
natal counseling)  among  ZIKV  victims  offer  new
opportunities  to  eliminate  ZIKV,  other  sexually
transmitted diseases  (STIs)  and  dengue  in  the  West-
ern hemisphere,  Paciﬁc  islands  and  some  parts
of sub-Saharan  Africa  [15,21].  Maternal  perina-
tal education  and  increasing  household  income  in
affected communities  can  have  a  signiﬁcant  impact
in reducing  child  deaths  and  maternal  vulnerabil-
ity. Moreover,  there  is  an  emerging  resurgence  of
dengue patterns  and  trend  in  poor  countries  and  the
Americas,  likely  related  to  climate  changes,  global
warming  and  intense  environmental  perturbations.
Strengthening  the  development  of  more  effective
and affordable  early  warning  signals  and  surveil-
lance  indicators  and  tools,  preventive  and  curative
treatments  to  improve  community  care  and  well-
ness are  needed  [1,5,19,21].
As indicated  in  Fig.  1, the  geographical  dis-
tribution of  ZIKV  and  dengue  from  Africa  to  the
Asian Paciﬁc  and  Latin  America  requires  further
detailed data  to  model  the  dynamics  of  vectors
and potential  ecological  including  climatic  impacts
over time  in  old  and  new  affected  or  vulnerable
countries.  For  example,  the  Pan-American  Health
Organization  (PAHO)  is making  robust  strides  in
identifying  and  supporting  research  areas  as  part
of its  response.  National  governments  and  stake-
holders  should  improve  efforts  to  reduce  inequality
and implement  fundamental  reforms  such  as  delay-
ing pregnancy  and  limiting  unnecessary  travel  [11].
Previous studies  have  shown  that  male  circumci-
sion, which  is  highly  practiced  in  West  Africa,  is
associated  with  a  lower  risk  of  ZIKV  and  other
e
f
i
tE.  Tambo  et  al.
exually  transmitted  diseases  compared  to  other
ountries  with  low/no  male  circumcision  rates
27,28].  Local  and  international  partnerships  with
ustainable  commitment  and  support  are  required
o halt  these  re-emerging  epidemics  by  leverag-
ng documented  progress  and  addressing  knowledge
aps in  achieving  signiﬁcant  reduction,  effective
ontrol and  containment  efforts.
Similar to  Ebola  outbreaks  in  West  Africa,  re-
merging vector-borne  infections  could  have  severe
mpacts on  maternal—child  healthcare  and  wors-
ning socio-economic  challenges  in  sub-Saharan
frica. Tackling  emerging  or  re-emerging  vector-
orne viral  disease  requires  more  proactive  and
oncrete  efforts  and  commitment  in  terms  of
limate  changes  and  environmental  protection,
itigation and  appropriate  adaptation  measure
evelopment  and  deployment  to  address  the  grow-
ng trends.  Innovative  approaches  in  vector  or  virus
ustained  surveillance,  monitoring  and  contain-
ent are  needed  and  require  signiﬁcant  attention
imilar to  what  has  been  done  with  MERS-CoV  and
engue  in  Saudi  Arabia,  H1N1  and  H7N9  avian
nﬂuenza in  China  [2,5,9,17,26,28].  Additionally,
urther research  is  needed  to  identify  and  map
he growing  patterns  of  resurgence.  Timely  explo-
ation  of  the  impacts  of  climate  changes,  changing
ost  interactions  and  environmental  impacts  on
ector-virus  genetic  evolution  and  ﬂow  as  well  as
opulation  immunity,  viral  competence  and  viru-
ence advantages  will  require  further  research.
Currently,  there  is  no  vaccine  or  curative  drug
vailable, although  highly  active  antiretroviral
herapy can  prolong  the  lives  of  infected  individuals
11]. Early  in  the  course  of  ZIKV  and  DENV  research,
he mysterious  diseases  were  perceived  as  illnesses
f forest  regions  [15]. Therefore,  infected  individ-
als were  able  to  silently  and  unknowingly  spread
he infection  for  years  [32]. In  contrast,  Ebola  and
IV infections  and  related  deaths  are  rapid  and
herefore  more  terrifying;  however,  dengue  cases
an be  identiﬁed  and  isolated  and  patient  con-
acts can  be  traced  and  monitored  [15,21].  As
ndicated  in  early  arbovirus  research,  most  health-
are workers  and  blood-transfused  patients  might
e infected  with  Zika  or  dengue  because  of  a
ack of  proper  diagnostic  capacities,  poor  eluci-
ation  of  the  routes  of  transmission,  pathogenesis
nd spread.  A  similar  effect  was  observed  among
engue or  ZIKV-infected  health  workers  during  the
arly history  of  the  disease.  In  addition,  lessons
earned from  the  global  dengue  response  should  be
xtended  to  ZIKV  in  a  timely  manner  [25].  Apart
rom  that,  Ebola  virus  requires  more  sophisticated
solation measures  to  contain  the  disease  [21,29]
han  does  Zika  or  dengue.
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Rika  and  dengue  epidemics  implications  for  global  m
There  is  an  urgent  need  to  support  Zika  and
engue research  aimed  at  the  development  and
mplementation  of  safe  and  effective  vaccine  and
rugs for  millions  of  vulnerable  mothers,  newborns
nd children.  It  is  also  important  to  expand  the
overage  of  innovative  high-impact  interventions
ncluding existing  immunization  campaigns  to  limit
hreatening  co-infections  and  ensure  the  survival
f women  and  children  [28,29,31,32].  Addressing
osquito vector  and  viral  surveillance  challenges
n the  context  of  limited  resources  or  urbanized
ettings is  necessary  for  effective  treatment  and
accine accessibility  and  availability  to  the  most
ard-to-reach  remote  areas  and  vulnerable  popu-
ations. Also  critical  is  addressing  the  shortage  of
rained ﬁeld  and  community  healthcare  workers,
eak health  systems,  weak  community  engage-
ent, lack  of  participation  in  early  identiﬁcation,
hallenging  diagnostics  and  self-reporting,  stigma-
ization and  weak  prompt  isolation/quarantine
acilities  [28,31—33]. The  burden  faced  by  chil-
ren and  mothers  highlights  the  importance  of
ncreasing  access  to  community  social  mobilization
nd participation,  health  education  and  aware-
ess programs,  facilities  and  effective  emergency
esponses, including  delivery  of  palliative  antiretro-
iral drugs  to  affected  communities,  tracking  and
racing of  suspected  cases  and  sexual  partners,
onitoring of  risk  factors  and  determinants  of
IKV and  DENV  threats  and  epidemic  resurgence
33—35].  Improving  health  systems  in  LIMCs  against
he transmission  dynamics  and  spread  of  ZIKV  and
ENV and  their  overlapping  characteristic  signs  and
ymptoms  is  challenging  due  to  clinical  and  diagnos-
ic limitations.
onclusion
here  is  an  urgent  need  to  improve  investment
n Zika,  dengue  and  other  infectious  disease
esearch and  development  on  evidence-informed
nd sustainable  policies  making  and  strategies
mplementation  to  avert  potential  impacts  in  low
nd middle  income  countries  (LIMCs).  Moreover,
trengthening the  Global  Health  Flavivirus  Net-
ork (GHFVN)  for  timely,  reliable  and  detailed
ata in  revamping  pragmatic,  evidence-based  and
ction-oriented  maternal—child  health  and  global
omen’s  wellbeing  is  imperative.  Implementing
ggressive and  strategic  innovative  interventions
o prevent  or  control  these  viral  diseases  will
e tantamount  to  directly  or  indirectly  in  pro-
oting capacity  building  and  empowerment  in
nderstanding  ZIKV  impacts  on  the  maternal—child
ealth burden.  Ultimately,  there  is  also  a  need  tornal-child  health  burden  249
romote  proactive  and  evidence-informed  pro-
rams and  intervention  delivery,  preparedness
tructural changes,  health  planning  and  emergency
esponse programs  and  quality  outcomes.
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